{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:22:42Z","timestamp":1792650162038,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.vaccine.2017.09.004","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T09:45:41Z","timestamp":1511775941000},"page":"322-330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Immunogenicity of Vibrio cholerae outer membrane vesicles secreted at various environmental conditions"],"prefix":"10.1016","volume":"36","author":[{"given":"Rezaei","family":"Adriani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Latif","family":"Mousavi Gargari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Sarvary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiseh","family":"Noroozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.09.004_b0005","doi-asserted-by":"crossref","first-page":"e106731","DOI":"10.1371\/journal.pone.0106731","article-title":"Outer membrane vesicles mediate transport of biologically active Vibrio cholerae cytolysin (VCC) from V. cholerae strains","volume":"9","author":"Elluri","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2017.09.004_b0010","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/IAI.01139-08","article-title":"Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera","volume":"77","author":"Schild","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.09.004_b0015","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1128\/IAI.00532-08","article-title":"Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice","volume":"76","author":"Schild","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.09.004_b0020","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.febslet.2011.04.017","article-title":"Association of cholera toxin with Vibrio cholerae outer membrane vesicles which are internalized by human intestinal epithelial cells","volume":"585","author":"Chatterjee","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2017.09.004_b0025","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1128\/IAI.00398-10","article-title":"Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility","volume":"78","author":"Bishop","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.09.004_b0030","unstructured":"Bronze MS, Greenfield RA. Biodefense: principles and pathogens. Norfolk (UK): Horizon Bioscience; 2005."},{"key":"10.1016\/j.vaccine.2017.09.004_b0035","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/infdis\/jir756","article-title":"Immunization of mice with Vibrio cholerae outer-membrane vesicles protects against hyperinfectious challenge and blocks transmission","volume":"205","author":"Bishop","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.004_b0040","doi-asserted-by":"crossref","first-page":"e1004405","DOI":"10.1371\/journal.ppat.1004405","article-title":"Insights into Vibrio cholerae intestinalcolonization from monitoring fluorescently labeled bacteria","volume":"10","author":"Millet","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2017.09.004_b0045","first-page":"2","article-title":"Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam","volume":"80","author":"Trach","year":"2002","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2017.09.004_b0050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0264-410X(92)90030-N","article-title":"Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers","volume":"10","author":"Jertborn","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.004_b0055","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0264-410X(93)90125-H","article-title":"Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers","volume":"11","author":"Jertborn","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.004_b0060","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","article-title":"Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.004_b0065","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.vaccine.2003.12.033","article-title":"Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR","volume":"22","author":"Viret","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.004_b0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1741-7007-8-129","article-title":"Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine","volume":"8","author":"Levine","year":"2010","journal-title":"BMC Biol"},{"key":"10.1016\/j.vaccine.2017.09.004_b0075","first-page":"7","article-title":"Gram-negative outer membrane vesicles in vaccine development","volume":"12","author":"Collins","year":"2011","journal-title":"Disc Med"},{"key":"10.1016\/j.vaccine.2017.09.004_b0080","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1099\/mic.0.2007\/009084-0","article-title":"Biochemical characterization of the enterotoxigenic Escherichia coli LeoA protein","volume":"153","author":"Brown","year":"2007","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2017.09.004_b0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/MMBR.00031-09","article-title":"Virulence and immunomodulatory roles of bacterial outer membrane vesicles","volume":"74","author":"Ellis","year":"2010","journal-title":"Microbiol Mol Biol Rev: MMBR"},{"key":"10.1016\/j.vaccine.2017.09.004_b0090","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1101\/gad.1299905","article-title":"Bacterial outer membrane vesicles and the host-pathogen interaction","volume":"19","author":"Kuehn","year":"2005","journal-title":"Genes Dev"},{"key":"10.1016\/j.vaccine.2017.09.004_b0095","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1472-4669.2008.00157.x","article-title":"Gram-negative outer membrane vesicles: beyond the cell surface","volume":"6","author":"Mashburn-Warren","year":"2008","journal-title":"Geobiology"},{"key":"10.1016\/j.vaccine.2017.09.004_b0100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.micro.091208.073413","article-title":"Biological functions and biogenesis of secreted bacterial outer membrane vesicles","volume":"64","author":"Kulp","year":"2010","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2017.09.004_b0105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1586\/erv.11.10","article-title":"Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines","volume":"10","author":"Sanders","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.09.004_b0110","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1002\/pmic.200500502","article-title":"Outer membrane vesicles of the VA-MENGOC-BC vaccine against serogroup B of Neisseria meningitidis: analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry","volume":"6","author":"Uli","year":"2006","journal-title":"Proteomics."},{"key":"10.1016\/j.vaccine.2017.09.004_b0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/bmb\/62.1.113","article-title":"Vaccines against human enteric bacterial pathogens","volume":"62","author":"Dougan","year":"2002","journal-title":"Br Med Bull"},{"key":"10.1016\/j.vaccine.2017.09.004_b0120","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1128\/IAI.72.10.5535-5547.2004","article-title":"Enteric pathogens as vaccine vectors for foreign antigen delivery","volume":"72","author":"Kotton","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.09.004_b0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-3659(99)00231-X","article-title":"Oral vaccine delivery","volume":"65","author":"Russell-Jones","year":"2000","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2017.09.004_b0130","first-page":"163","article-title":"Colon specific drug delivery systems: a review on various pharmaceutical approaches","volume":"2","author":"Prasanth","year":"2012","journal-title":"J Appl Pharmaceut Sci"},{"key":"10.1016\/j.vaccine.2017.09.004_b0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jconrel.2014.03.054","article-title":"Controlled drug delivery systems: past forward and future back","volume":"190","author":"Park","year":"2014","journal-title":"J Control Release: Off J Control Release Soc"},{"key":"10.1016\/j.vaccine.2017.09.004_b0140","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1586\/erv.10.89","article-title":"Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses","volume":"9","author":"Oyewumi","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.09.004_b0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0928-0987(01)00172-5","article-title":"Chitosan and its derivatives in mucosal drug and vaccine delivery","volume":"14","author":"van der Lubben","year":"2001","journal-title":"Eur J Pharm. Sci: Off J Eur Fed Pharm Sci"},{"key":"10.1016\/j.vaccine.2017.09.004_b0150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0169-409X(01)00197-1","article-title":"Chitosan for mucosal vaccination","volume":"52","author":"van der Lubben","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2017.09.004_b0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/nano.2006.1.2.117","article-title":"Chitosan nanoparticles for oral drug and gene delivery","volume":"1","author":"Bowman","year":"2006","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.vaccine.2017.09.004_b0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0168-3659(97)00203-4","article-title":"Design of microencapsulated chitosan microspheres for colonic drug delivery","volume":"52","author":"Lorenzo-Lamosa","year":"1998","journal-title":"J Control Release: Off J Control Release Soc"},{"key":"10.1016\/j.vaccine.2017.09.004_b0165","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/03639040701377904","article-title":"Eudragit coating of chitosan-prednisolone conjugate microspheres and in vitro evaluation of coated microspheres","volume":"33","author":"Onishi","year":"2007","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.vaccine.2017.09.004_b0170","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2008.04.003","article-title":"pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres","volume":"359","author":"Quan","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2017.09.004_b0175","first-page":"3916","article-title":"Purification and visualization of lipopolysaccharide from gram-negative bacteria by hot aqueous-phenol extraction","author":"Davis","year":"2012","journal-title":"J Visual Exp JoVE"},{"key":"10.1016\/j.vaccine.2017.09.004_b0180","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ab.2012.10.038","article-title":"A scalable method for O-antigen purification applied to various salmonella serovars","volume":"434","author":"Micoli","year":"2013","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2017.09.004_b0185","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.5007","article-title":"Biological and immunological evaluation of Neisseria meningitidis serogroup a outer membrane vesicle as vaccine candidates","volume":"6","author":"Delbaz","year":"2013","journal-title":"Jundishapur J Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2017.09.004_b0190","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.progpolymsci.2011.01.001","article-title":"Polymer nanoparticles: preparation techniques and size-control parameters","volume":"36","author":"Rao","year":"2011","journal-title":"Prog Polym Sci"},{"key":"10.1016\/j.vaccine.2017.09.004_b0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1574-6968.1998.tb12924.x","article-title":"Lack of protection following immunisation with H. pylori outer membrane vesicles highlights antigenic differences between H. felis and H. pylori","volume":"161","author":"Keenane","year":"1998","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2017.09.004_b0200","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1128\/IAI.73.7.4070-4080.2005","article-title":"Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination","volume":"73","author":"Fisseha","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.09.004_b0205","doi-asserted-by":"crossref","first-page":"e2293","DOI":"10.1371\/journal.pntd.0002293","article-title":"An adultmouse model of Vibrio cholerae-induced diarrhea for studying pathogenesis and potential therapy of cholera","volume":"7","author":"Sawasvirojwong","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.09.004_b0210","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/psc.2930","article-title":"Development of lipopolysaccharide-mimicking peptides and their immunoprotectivity against Vibrio cholerae serogroup O1","volume":"22","author":"Mohammad pour","year":"2016","journal-title":"J Pept Sci"},{"key":"10.1016\/j.vaccine.2017.09.004_b0215","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1348-0421.1993.tb03192.x","article-title":"Release of the outer membrane vesicles from Vibrio cholerae and Vibrio parahaemolyticus","volume":"37","author":"Kondo","year":"1993","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2017.09.004_b0220","first-page":"81","article-title":"Outer membrane protein vesicle vaccines for meningococcal disease","volume":"66","author":"Frasch","year":"2001","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.vaccine.2017.09.004_b0225","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-3083.2012.02709.x","article-title":"An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt","volume":"76","author":"Norheim","year":"2012","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2017.09.004_b0230","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1016\/j.vaccine.2010.04.082","article-title":"Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process","volume":"28","author":"van de Waterbeemd","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.004_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00121","article-title":"Bacterial outer membrane vesicles and vaccine applications","volume":"5","author":"Acevedo","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2017.09.004_b0240","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4161\/hv.7.8.16086","article-title":"Next-generation outer membrane vesicle vaccines against Neisseriameningitidis based on nontoxic LPS mutants","volume":"7","author":"van der Ley","year":"2011","journal-title":"Human Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.004_b0245","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1128\/JB.02192-12","article-title":"Synthetic effect between envelope stress and lack of outer membrane vesicle production in Escherichia coli","volume":"195","author":"Schwechheimer","year":"2013","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2017.09.004_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micres.2014.09.006","article-title":"Methods of isolation and purification of outer membrane vesicles from gram-negative bacteria","volume":"170","author":"Klimentov\u00e1","year":"2015","journal-title":"Microbiol Res"},{"key":"10.1016\/j.vaccine.2017.09.004_b0255","first-page":"2010","article-title":"Preparation and characterization of water-soluble chitosan nanoparticles as protein delivery system","author":"Zhang","year":"2010","journal-title":"J Nanomater"},{"key":"10.1016\/j.vaccine.2017.09.004_b0260","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1016\/j.vaccine.2013.05.020","article-title":"Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice","volume":"31","author":"Camacho","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2017.09.004_b0265","first-page":"e221","article-title":"Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh","volume":"2","author":"Harris","year":"2008","journal-title":"Plos One"},{"key":"10.1016\/j.vaccine.2017.09.004_b0270","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1128\/IAI.01382-12","article-title":"Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen","volume":"81","author":"Leitner","year":"2013","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17312045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17312045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:24:22Z","timestamp":1759400662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17312045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0264410X17312045"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of Vibrio cholerae outer membrane vesicles secreted at various environmental conditions","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}